Unite with industry leaders to delve into regulatory shifts, enforcement trends and risk management guidance to fortify your compliance program.
Partner Scott Liebman will be speaking on the panel "Policy Shifts Under the New Administration – Implications for Life Sciences" on September 4 from 9:45-10:30 AM.
Topics:
- Explore recent executive orders implemented by the new administration and resulting shifts in the regulatory and enforcement landscapes
- Examine impact on the pharma/biotech/MedTech industry and discuss how compliance programs are reacting
Click here to register.